4.1 Article

Prevalence of anxiety disorders among Finnish primary care high utilizers and validation of Finnish translation of GAD-7 and GAD-2 screening tools

期刊

出版社

TAYLOR & FRANCIS LTD
DOI: 10.3109/02813432.2014.920597

关键词

Anxiety disorders; Finland; generalized anxiety disorder; general practice; high utilizers of health care; panic disorder; screening

资金

  1. Northern Finland health care support foundation
  2. Astra Zeneca
  3. Oy Bristol-Myers Squibb (Finland) Ab
  4. Eli Lilly
  5. Pfizer Oy
  6. Servier Finland Oy
  7. H. Lundbeck A/S

向作者/读者索取更多资源

To analyse the prevalence of GAD and other anxiety disorders, as well as sensitivity and specificity of GAD-7 among high utilizers of health care. Setting. Four municipal health centres in Northern Finland. Subjects. A psychiatric interview was conducted for 150 high utilizers of health care. Main outcome measures. Prevalence of GAD as well as sensitivity and specifi city of GAD-7. Results. The prevalence of GAD was 4% in this study group of Finnish high utilizers of health care. The sensitivity of GAD-7 was 100.0% (95% CI 54.1-100.0) and the specifi city of GAD-7 was 82.6% (95% CI 75.4 -88.4) with a cut-off point of 7 or more. Conclusion. GAD is rather common among high utilizers of primary care, although the prevalence of 4% is lower than that previously reported. GAD-7 is a valid and useful tool for detecting GAD among primary health care patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据